Target Name: RASSF9
NCBI ID: G9182
Review Report on RASSF9 Target / Biomarker Content of Review Report on RASSF9 Target / Biomarker
RASSF9
Other Name(s): PAMCI | peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor protein-1 | P-CIP1 | Ras association domain family protein 9 (RASSF9) | Ras association domain family member 9 | PAM COOH-terminal interactor protein 1 | PCIP1 | Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor | Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor protein-1 | Ras association domain-containing protein 9 | RASF9_HUMAN | Ras association (RalGDS/AF-6) domain family (N-terminal) member 9

RASSF9: A Potential Drug Target and Biomarker

RASSF9 (RNA-associated protein with multiple introns) is a protein that is expressed in various cell types of the human body, including epithelial, hematopoietic, and nervous tissues. It is a non-coding RNA molecule that plays a crucial role in the regulation of gene expression and has been implicated in various cellular processes. While the exact function of RASSF9 is not yet fully understood, research has shown that it to be involved in the development and maintenance of cancer. In this article, we will explore the potential implications of RASSF9 as a drug target and biomarker.

The RASSF9 gene

RASSF9 is a gene that encodes a protein of approximately 21 kDa. The protein is composed of multiple introns, which are regions of the gene that do not code for amino acids. The introns are transcribed from DNA into RNA and then translated into protein. The RASSF9 gene is located on chromosome 19 at position 616.2.

Expression of RASSF9

RASSF9 is expressed in a wide variety of cell types, including epithelial, hematopoietic, and nervous tissues. It is highly expressed in the epithelial tissue, which forms the lining of various body surfaces and organs. RASSF9 is also expressed in the hematopoietic tissue, which is responsible for the production of blood cells. In addition, RASSF9 is expressed in the nervous tissue, where it is involved in the regulation of neuronal communication.

Function of RASSF9

While the exact function of RASSF9 is not yet fully understood, research has shown that it to be involved in the regulation of gene expression, cell signaling, and apoptosis.

One of the known functions of RASSF9 is its role in cell signaling. RASSF9 has been shown to play a role in the regulation of T-cell development and function. Studies have shown that RASSF9 can modulate the activity of the transcription factor PDGF-1, which is involved in the development and progression of cancer.

Another function of RASSF9 is its role in apoptosis. RASSF9 has been shown to be involved in the regulation of cell apoptosis, which is a natural process that helps the body eliminate damaged or dysfunctional cells.

Potential drug targets

The potential drug targets for RASSF9 are numerous. One of the most promising targets is the inhibition of RASSF9 activity, which could lead to the inhibition of the regulation of gene expression and the inhibition of cell signaling.

Another potential drug target for RASSF9 is the inhibition of RASSF9-mediated apoptosis. This could lead to the inhibition of cell death and the potential for therapeutic applications in diseases where cell death is unwanted, such as cancer.

Biomarkers

RASSF9 has also been shown to be a potential biomarker for various diseases. For example, RASSF9 has been shown to be downregulated in various types of cancer, including breast, lung, and ovarian cancer. This suggests that RASSF9 may be a useful biomarker for the diagnosis and monitoring of these diseases.

Conclusion

In conclusion, RASSF9 is a protein that has been shown to play a role in the regulation of gene expression, cell signaling, and apoptosis. Its potential drug targets are numerous, including the inhibition of RASSF9 activity, the inhibition of RASSF9-mediated apoptosis, and the use as a biomarker for various diseases. Further research is needed to fully understand the functions of RASSF9 and its potential as a drug target.

Protein Name: Ras Association Domain Family Member 9

Functions: May play a role in regulating vesicuar trafficking in cells

The "RASSF9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RASSF9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RAVER1 | RAVER2 | RAX | RAX2 | RB1 | RB1-DT | RB1CC1 | RBAK | RBAK-RBAKDN | RBAKDN | RBBP4 | RBBP4P2 | RBBP4P6 | RBBP5 | RBBP6 | RBBP7 | RBBP8 | RBBP8NL | RBBP9 | RBCK1 | RBFA | RBFOX1 | RBFOX2 | RBFOX3 | RBIS | RBKS | RBL1 | RBL2 | RBM10 | RBM11 | RBM12 | RBM12B | RBM14 | RBM14-RBM4 | RBM15 | RBM15-AS1 | RBM15B | RBM17 | RBM17P1 | RBM18 | RBM19 | RBM20 | RBM22 | RBM22P1 | RBM23 | RBM24 | RBM25 | RBM26 | RBM26-AS1 | RBM27 | RBM28 | RBM3 | RBM33 | RBM34 | RBM38 | RBM39 | RBM4 | RBM41 | RBM42 | RBM43 | RBM43P1 | RBM44 | RBM45 | RBM46 | RBM47 | RBM48 | RBM48P1 | RBM4B | RBM5 | RBM5-AS1 | RBM6 | RBM7 | RBM8A | RBMS1 | RBMS1P1 | RBMS2 | RBMS2P1 | RBMS3 | RBMS3-AS3 | RBMX | RBMX2 | RBMX2P1 | RBMXL1 | RBMXL2 | RBMXL3 | RBMY1A1 | RBMY1B | RBMY1D | RBMY1F | RBMY1J | RBMY2EP | RBMY2FP | RBP1 | RBP2 | RBP3 | RBP4 | RBP5 | RBP7 | RBPJ | RBPJL